Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Anti-Cancer Inhibitor Could Have Dual Effect
Disease Discoveries

Anti-Cancer Inhibitor Could Have Dual Effect

By Will DossOct 21, 2021
Share
Facebook Twitter Email
Daniela Matei, MD, the Diana, Princess of Wales Professor of Cancer Research, chief of Reproductive Science in Medicine in the Department of Obstetrics and Gynecology, was senior author of the study published in the Journal for Immunotherapy of Cancer.

TG2, an enzyme known to help cancers spread more quickly, also plays a role in regulating T-cells, according to a Northwestern Medicine study published in the Journal for Immunotherapy of Cancer.

Inhibiting TG2 in non-cancer cells also boosted immune activity, a phenomenon that could be leveraged in cancer therapy, according to Daniela Matei, MD, the Diana, Princess of Wales Professor of Cancer Research, chief of Reproductive Science in Medicine in the Department of Obstetrics and Gynecology and senior author of the study.

“If we create a drug that inhibits TG2, it could work in cancer cells and in host cells,” said Matei, who is also a professor of Medicine in the Division of Hematology and Oncology.

Matei’s laboratory has studied the impact of elevated TG2 expression in ovarian cancer for a decade, consistently finding that TG2 increases ovarian cancer’s spread to other locations in the body. However, what impact TG2 has in normal cells remained unknown.

In the current study, Matei and co-author Bin Zhang, MD, PhD, professor of Medicine in the Division of Hematology and Oncology and of Microbiology-Immunology, studied the effects of knocking out expression of the gene that codes for TG2 in mouse models of ovarian cancer.

The investigators discovered that, surprisingly, loss of TG2 in healthy cells is accompanied by a more robust immune response. Without TG2, an imbalance in STAT proteins causes increased cytotoxic T-cell activity, leading to reduced tumor progression.

“TG2 is necessary in the body, so we believe loss of TG2 triggers this compensatory mechanism,” Matei said.

Matei and collaborators are currently exploring strategies to inhibit TG2 in cancer cells, but now are designing inhibitors that will work in immune cells as well.

“Our current inhibitor is designed to block adhesion of cancer cells to the extracellular matrix, but other approaches can degrade the entire TG2 protein — which could help kill cancer cells, alter anti-tumor immunity and delay cancer progression,” Matei said.

Zhang and Matei are members of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

This research was supported by U.S. Department of Veterans Affairs grant I01 BX000792-06, the Diana Princess of Wales endowed Professorship from the Robert H. Lurie Comprehensive Cancer Center, the Walter S. and Lucienne Driskill Immunotherapy Research fund and UEFISCDI grant PN-III-P1-1.1-TE- 2019-0670.

Cancer Genetics Research
Share. Facebook Twitter Email

Related Posts

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

Comments are closed.

Latest News

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230315_NM036
20230315_NM046
20230315_NM134
20230315_NM205
20230315_NM206
20230315_NM132
20230315_NM130
20230315_NM082
20230315_NM063
20230315_NM058
20230315_NM030
20230315_NM038

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.